Low Dose Alemtuzumab (Campath 1H) Prior to Allogeneic Stem Cell Transplantation Is Associated with Low Incidence of Acute and Chronic GVHD but Protracted Immune Recovery von Devetten, Marcel P., Loberiza, Fausto, Weisenborn, Robin, Bunner, Pam, Brewer, Jamie, Ericson, Solveig

Volltext

Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit von Kurian, Sobha, Qazilbash, Muzzafar, Fay, Joseph, Wolff, S., Herzig, Roger, Hobbs, Gerry, Bunner, Pam, Weisenborn, Robin, Aya-ay, Melanie, Lynch, Joseph, Ericson, Solveig

Volltext

Utility of a Prognostic Scoring System for Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia von Qazilbash, Muzaffar H., Devetten, Marcel P., Abraham, Jame, Lynch, Joseph P., Beall, Charles L., Weisenborn, Robin, Bunner, Pam, Ericson, Solveig G.

Volltext

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model von Qazilbash, Muzaffar H., Devetten, Marcel P., Abraham, Jame, Lynch, Joseph P., Beall, Charles L., Auber, Miklos, Weisenborn, Robin, Bunner, Pam, Ericson, Solveig G.

Volltext